United Nation’s Children Fund (UNICEF)

An initial purchase of the steroid dexamethasone, shown to be effective in treating severe or critical COVID-19 patients, will be made for up to 4.5 million people in low- and middle-income countries, agencies said on Friday.

The U.N. Children’s Fund (UNICEF) is negotiating the advance purchase under the deal led by UNITAID and Wellcome, as part of the World Health Organization’s plan to accelerate access to therapeutics, a joint statement said.


“With this advanced purchase we aim to ensure equitable access for low- and middle-income countries for treatment of COVID-19 with the life-saving drug dexamethasone, and avoid shortages resulting from high-levels of demand from other parts of the world,” said Philippe Duneton, acting executive director of UNITAID.

Get more stories like this on Twitter

AD: To get thousands of free final year project topics and other project materials sorted by subject to help with your research [click here]


More Stories